Evolving therapies for the treatment of chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

Evolving therapies for the treatment of chronic hepatitis B virus infection

Published:2002-02 Issue:2 Volume:11 Page:169-187
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

IV William E Delaney¹,Bartholomeusz Angeline²,Locarnini Stephen A²

Affiliation:

1. Gilead Sciences, 333 Lakeside Drive, Foster City, CA 94402, USA

2. Victorian Infectious Diseases Reference Laboratory, Locked Bag 815, Carlton South, VIC 3053, Australia, Tel.: +61 3 9342 2614; Fax: +61 3 9432 2666;, E-mail: stephenlocarnini@compuserve.com

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.11.2.169

Reference124 articles.

1. Global programme for control of hepatitis B infection

2. HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS

3. Hepatitis B Virus Infection

4. Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA.

5. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents;European Journal of Medicinal Chemistry;2015-01

2. A new strategy for constructing in vitro replication-competent 1.3 copies of hepatitis B virus genome;Journal of Virological Methods;2009-10

3. Hepatitis B: Where Are We Today?;Transfusion Medicine and Hemotherapy;2006

4. Synthesis of [14C]-radiolabelled entecavir;Journal of Labelled Compounds and Radiopharmaceuticals;2005

5. Treatments for Hepatitis B;Clinical Infectious Diseases;2004-11-01